Evidence map›Paper›PMID 37441339›Full record

ArticleJournal of big data2023

The evolution of Big Data in neuroscience and neurology.

Laura Dipietro, Paola Gonzalez-Mego, Ciro Ramos-Estebanez, Lauren Hana Zukowski, Rahul Mikkilineni, Richard Jarrett Rushmore, Timothy Wagner

Abstract read
In one paragraph

Article in Journal of big data, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. New Challenges for Anatomists in the Era of Omics.Diagnostics (Basel, Switzerland) · 2023
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura DipietroHighland Instruments, Cambridge, MA USA.
Paola Gonzalez-MegoSpaulding Rehabilitation/Neuromodulation Lab, Harvard Medical School, Cambridge, MA USA.
Ciro Ramos-EstebanezUniversity of Illinois Chicago, Chicago, IL USA.
Lauren Hana ZukowskiCase Western University, Cleveland, OH USA.
Rahul MikkilineniCase Western University, Cleveland, OH USA.
Richard Jarrett RushmoreBoston University, Boston, MA USA.
Timothy WagnerHighland Instruments, Cambridge, MA USA.

Funding

Unraveling the Superficial White Matter of the Primate Brain: Tracer-Based Histology and dMRI Tractography ValidationR01NS125307 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI NIKOLAOS MAKRIS, RICHARD Jarrett RUSHMORE · 2022 to 2026
$3.4M
ESStim for the Treatment of Postural Instability in Patients with Parkinson's Disease - Phase IIBR44NS110237 · NINDS · HIGHLAND INSTRUMENTS, INC. · PI Laura Dipietro, Timothy Andrew Wagner · 2019 to 2026
$3.2M
Noninvasive Brain Stimulation for Treating Addiction (Supplement)R44DA049685 · NIDA · HIGHLAND INSTRUMENTS, INC. · PI DIPIETRO, LAURA, WAGNER, TIMOTHY ANDREW · 2019 to 2024
$3.0M
Optimizing Technology and Treatment for Non Specific Chronic Low Back PainR44AG055360 · NIA · HIGHLAND INSTRUMENTS, INC. · PI DIPIETRO, LAURA, WAGNER, TIMOTHY ANDREW · 2016 to 2020
$1.7M
Enhancing Physical Therapy: Noninvasive Brain Stimulation System for Treating Carpal Tunnel SyndromeR44AR076885 · NIAMS · HIGHLAND INSTRUMENTS, INC. · PI DIPIETRO, LAURA, WAGNER, TIMOTHY ANDREW · 2019 to 2023
$1.7M
Optimization of Non Invasive Brain Stimulation for Diabetic Neuropathic PainR44DK117710 · NIDDK · HIGHLAND INSTRUMENTS, INC. · PI DIPIETRO, LAURA, WAGNER, TIMOTHY ANDREW · 2018 to 2022
$1.0M
Stroke Assessment SuiteR43NS113737 · NINDS · HIGHLAND INSTRUMENTS, INC. · PI DIPIETRO, LAURA, WAGNER, TIMOTHY ANDREW · 2019 to 2019
$224k
NIAMS NIH HHS R44 AR076885NIA NIH HHS R44 AG055360NIDA NIH HHS R44 DA049685NIDDK NIH HHS R44 DK117710NINDS NIH HHS R01 NS125307NINDS NIH HHS R43 NS113737NINDS NIH HHS R44 NS110237
6 · The paper itself

Abstract

Neurological diseases are on the rise worldwide, leading to increased healthcare costs and diminished quality of life in patients. In recent years, Big Data has started to transform the fields of Neuroscience and Neurology. Scientists and clinicians are collaborating in global alliances, combining diverse datasets on a massive scale, and solving complex computational problems that demand the utilization of increasingly powerful computational resources. This Big Data revolution is opening new avenues for developing innovative treatments for neurological diseases. Our paper surveys Big Data's impact on neurological patient care, as exemplified through work done in a comprehensive selection of areas, including Connectomics, Alzheimer's Disease, Stroke, Depression, Parkinson's Disease, Pain, and Addiction (e.g., Opioid Use Disorder). We present an overview of research and the methodologies utilizing Big Data in each area, as well as their current limitations and technical challenges. Despite the potential benefits, the full potential of Big Data in these fields currently remains unrealized. We close with recommendations for future research aimed at optimizing the use of Big Data in Neuroscience and Neurology for improved patient outcomes. Supplementary Information: The online version contains supplementary material available at 10.1186/s40537-023-00751-2.

Indexed as

AddictionAlzheimer’sArtificial IntelligenceBig dataBrain StimulationDepressionNeurologyNeurosciencePainStroke

Identifiers

PMID37441339
PMCPMC10333390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.